• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用造影前及钆塞酸增强磁共振成像鉴别肝内胆管癌与低分化肝细胞癌

Distinguishing intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma using precontrast and gadoxetic acid-enhanced MRI.

作者信息

Asayama Yoshiki, Nishie Akihiro, Ishigami Kousei, Ushijima Yasuhiro, Takayama Yukihisa, Fujita Nobuhiro, Kubo Yuichiro, Aishima Shinichi, Shirabe Ken, Yoshiura Takashi, Honda Hiroshi

机构信息

Department of Radiology, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.

出版信息

Diagn Interv Radiol. 2015 Mar-Apr;21(2):96-104. doi: 10.5152/dir.2014.13013.

DOI:10.5152/dir.2014.13013
PMID:25698097
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4463313/
Abstract

PURPOSE

We aimed to gain further insight in magnetic resonance imaging characteristics of mass-forming intrahepatic cholangiocarcinoma (mICC), its enhancement pattern with gadoxetic acid contrast agent, and distinction from poorly differentiated hepatocellular carcinoma (pHCC).

METHODS

Fourteen mICC and 22 pHCC nodules were included in this study. Two observers recorded the tumor shape, intratumoral hemorrhage, fat on chemical shift imaging, signal intensity at the center of the tumor on T2-weighted image, fibrous capsule, enhancement pattern on arterial phase of dynamic study, late enhancement three minutes after contrast injection (dynamic late phase), contrast uptake on hepatobiliary phase, apparent diffusion coefficient, vascular invasion, and intrahepatic metastasis.

RESULTS

Late enhancement was more common in mICC (n=10, 71%) than in pHCC (n=3, 14%) (P < 0.001). A fat component was observed in 11 pHCC cases (50%) versus none of mICC cases (P = 0.002). Fibrous capsule was observed in 13 pHCC cases (59%) versus none of mICC cases (P < 0.001). On T2-weighted images a hypointense area was seen at the center of the tumor in 43% of mICC (6/14) and 9% of pHCC (2/22) cases (P = 0.018). Other parameters were not significantly different between the two types of nodules.

CONCLUSION

The absence of fat and fibrous capsule, and presence of enhancement at three minutes appear to be most characteristic for mICC and may help its differentiation from pHCC.

摘要

目的

我们旨在进一步深入了解肿块型肝内胆管癌(mICC)的磁共振成像特征、其使用钆塞酸二钠造影剂的强化模式以及与低分化肝细胞癌(pHCC)的鉴别。

方法

本研究纳入了14个mICC结节和22个pHCC结节。两名观察者记录肿瘤形态、瘤内出血、化学位移成像上的脂肪、T2加权图像上肿瘤中心的信号强度、纤维包膜、动态研究动脉期的强化模式、注射造影剂三分钟后的延迟强化(动态延迟期)、肝胆期的造影剂摄取、表观扩散系数、血管侵犯和肝内转移。

结果

mICC(n = 10,71%)中延迟强化比pHCC(n = 3,14%)更常见(P < 0.001)。11例pHCC病例(50%)观察到脂肪成分,而mICC病例均未观察到(P = 0.002)。13例pHCC病例(59%)观察到纤维包膜,而mICC病例均未观察到(P < 0.001)。在T2加权图像上,43%的mICC(6/14)和9%的pHCC(2/22)病例在肿瘤中心可见低信号区(P = 0.018)。两种类型的结节之间其他参数无显著差异。

结论

无脂肪和纤维包膜以及三分钟时出现强化似乎是mICC最具特征性的表现,可能有助于其与pHCC的鉴别。

相似文献

1
Distinguishing intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma using precontrast and gadoxetic acid-enhanced MRI.利用造影前及钆塞酸增强磁共振成像鉴别肝内胆管癌与低分化肝细胞癌
Diagn Interv Radiol. 2015 Mar-Apr;21(2):96-104. doi: 10.5152/dir.2014.13013.
2
Differentiation of mass-forming intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma: based on the multivariate analysis of contrast-enhanced computed tomography findings.基于多变量分析的增强 CT 表现对肿块型肝内胆管细胞癌与低分化肝细胞癌的鉴别诊断
Abdom Radiol (NY). 2016 May;41(5):978-89. doi: 10.1007/s00261-015-0629-z.
3
Differentiation of intrahepatic mass-forming cholangiocarcinoma from hepatocellular carcinoma on gadoxetic acid-enhanced liver MR imaging.钆塞酸二钠增强肝脏磁共振成像上肝内肿块型胆管癌与肝细胞癌的鉴别诊断
Eur Radiol. 2016 Jun;26(6):1808-17. doi: 10.1007/s00330-015-4005-8. Epub 2015 Sep 15.
4
Distinguishing intrahepatic mass-forming biliary carcinomas from hepatocellular carcinoma by computed tomography and magnetic resonance imaging using the Bayesian method: a bi-center study.应用贝叶斯方法通过 CT 和 MRI 鉴别肝内肿块型胆管细胞癌和肝细胞癌:一项双中心研究。
Eur Radiol. 2020 Nov;30(11):5992-6002. doi: 10.1007/s00330-020-06972-w. Epub 2020 Jun 4.
5
Small intrahepatic mass-forming cholangiocarcinoma: target sign on diffusion-weighted imaging for differentiation from hepatocellular carcinoma.小肝内肿块型胆管癌:扩散加权成像上的靶征用于与肝细胞癌鉴别
Abdom Imaging. 2013 Aug;38(4):793-801. doi: 10.1007/s00261-012-9943-x.
6
MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma.MRI 特征在肝细胞癌-胆管细胞癌与肿块型肝内胆管细胞癌的对比。
Cancer Imaging. 2018 Feb 27;18(1):8. doi: 10.1186/s40644-018-0142-z.
7
Imaging features of hepatic sarcomatous carcinoma on computed tomography and gadoxetic acid-enhanced magnetic resonance imaging.CT 和钆塞酸增强磁共振成像上肝肉瘤样癌的影像学特征。
Abdom Radiol (NY). 2017 May;42(5):1424-1433. doi: 10.1007/s00261-016-1038-7.
8
Differentiating mass-forming intrahepatic cholangiocarcinoma from atypical hepatocellular carcinoma using gadoxetic acid-enhanced MRI.使用钆塞酸增强 MRI 鉴别富血供型肝内胆管细胞癌与不典型肝细胞癌。
Clin Radiol. 2012 Aug;67(8):766-73. doi: 10.1016/j.crad.2012.01.004. Epub 2012 Mar 15.
9
Typical and atypical imaging findings of intrahepatic cholangiocarcinoma using gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging.使用钆乙氧基苄基二乙三胺五乙酸增强磁共振成像的肝内胆管癌的典型和非典型影像学表现
J Comput Assist Tomogr. 2012 Nov-Dec;36(6):704-9. doi: 10.1097/RCT.0b013e3182706562.
10
Differentiation between inflammatory myofibroblastic tumor and cholangiocarcinoma manifesting as target appearance on gadoxetic acid-enhanced MRI.在钆塞酸增强 MRI 上表现为靶征的炎性肌纤维母细胞瘤与胆管细胞癌的鉴别诊断。
Abdom Radiol (NY). 2019 Apr;44(4):1395-1406. doi: 10.1007/s00261-018-1847-y.

引用本文的文献

1
Diagnostic value of quantitative DWI and IVIM parameters in differentiating intrahepatic cholangiocarcinoma and hepatocellular carcinoma: a systematic review and meta-analysis.定量扩散加权成像(DWI)和体素内不相干运动(IVIM)参数在鉴别肝内胆管癌和肝细胞癌中的诊断价值:一项系统评价和荟萃分析
Abdom Radiol (NY). 2025 Aug 22. doi: 10.1007/s00261-025-05072-x.
2
Diagnostic performance of magnetic resonance imaging and contrast-enhanced ultrasound in differentiating intrahepatic cholangiocarcinoma from hepatocellular carcinoma: a meta-analysis.磁共振成像和超声造影对鉴别肝内胆管细胞癌与肝细胞癌的诊断性能:荟萃分析。
Abdom Radiol (NY). 2024 Jan;49(1):34-48. doi: 10.1007/s00261-023-04064-z. Epub 2023 Oct 12.
3
Contrast-Enhanced Imaging in the Management of Intrahepatic Cholangiocarcinoma: State of Art and Future Perspectives.对比增强成像在肝内胆管癌管理中的应用:现状与未来展望
Cancers (Basel). 2023 Jun 28;15(13):3393. doi: 10.3390/cancers15133393.
4
Machine learning based on gadoxetic acid-enhanced MRI for differentiating atypical intrahepatic mass-forming cholangiocarcinoma from poorly differentiated hepatocellular carcinoma.基于钆塞酸二钠增强磁共振成像的机器学习用于鉴别非典型肝内肿块型胆管癌与低分化肝细胞癌
Abdom Radiol (NY). 2023 Aug;48(8):2525-2536. doi: 10.1007/s00261-023-03870-9. Epub 2023 May 11.
5
Imaging Spectrum of Intrahepatic Mass-Forming Cholangiocarcinoma and Its Mimickers: How to Differentiate Them Using MRI.肝内肿块型胆管细胞癌及其模拟病变的影像学表现:MRI 如何对其进行鉴别。
Curr Oncol. 2022 Jan 30;29(2):698-723. doi: 10.3390/curroncol29020061.
6
Value of perfusion parameters histogram analysis of triphasic CT in differentiating intrahepatic mass forming cholangiocarcinoma from hepatocellular carcinoma.三期 CT 灌注参数直方图分析鉴别肝内肿块型胆管细胞癌与肝细胞癌的价值。
Sci Rep. 2021 Nov 30;11(1):23163. doi: 10.1038/s41598-021-02667-4.
7
Quantitative evaluation of focal liver lesions with T1 mapping using a phase-sensitive inversion recovery sequence on gadoxetic acid-enhanced MRI.使用钆塞酸增强MRI上的相位敏感反转恢复序列通过T1映射对肝脏局灶性病变进行定量评估。
Eur J Radiol Open. 2020 Dec 24;8:100312. doi: 10.1016/j.ejro.2020.100312. eCollection 2021.
8
Hepatocellular carcinoma (HCC) versus non-HCC: accuracy and reliability of Liver Imaging Reporting and Data System v2018.肝细胞癌(HCC)与非 HCC:肝脏影像报告和数据系统 v2018 的准确性和可靠性。
Abdom Radiol (NY). 2019 Jun;44(6):2116-2132. doi: 10.1007/s00261-019-01948-x.
9
Capsule, septum, and T2 hyperintense foci for differentiation between large hepatocellular carcinoma (≥5 cm) and intrahepatic cholangiocarcinoma on gadoxetic acid MRI.囊泡、隔膜和 T2 高信号灶在钆塞酸 MRI 鉴别 5cm 以上大肝癌和肝内胆管细胞癌中的作用。
Eur Radiol. 2017 Nov;27(11):4581-4590. doi: 10.1007/s00330-017-4846-4. Epub 2017 May 12.
10
Added value of smooth hypointense rim in the hepatobiliary phase of gadoxetic acid-enhanced MRI in identifying tumour capsule and diagnosing hepatocellular carcinoma.钆塞酸二钠增强MRI肝胆期平滑低信号环在识别肿瘤包膜及诊断肝细胞癌中的附加价值
Eur Radiol. 2017 Jun;27(6):2610-2618. doi: 10.1007/s00330-016-4634-6. Epub 2016 Oct 21.

本文引用的文献

1
1.5 tesla magnetic resonance imaging scanners compared with 3.0 tesla magnetic resonance imaging scanners: systematic review of clinical effectiveness.1.5特斯拉磁共振成像扫描仪与3.0特斯拉磁共振成像扫描仪的比较:临床有效性的系统评价
CADTH Technol Overv. 2012;2(2):e2201. Epub 2012 Jun 1.
2
Intrahepatic mass-forming cholangiocarcinoma: enhancement patterns on gadoxetic acid-enhanced MR images.肝内肿块型胆管细胞癌:钆塞酸增强磁共振成像的增强模式。
Radiology. 2012 Sep;264(3):751-60. doi: 10.1148/radiol.12112308. Epub 2012 Jul 12.
3
The uptake transporter OATP8 expression decreases during multistep hepatocarcinogenesis: correlation with gadoxetic acid enhanced MR imaging.多步骤肝癌发生过程中摄取转运体 OATP8 表达降低:与钆塞酸增强磁共振成像的相关性。
Eur Radiol. 2011 Oct;21(10):2056-66. doi: 10.1007/s00330-011-2165-8. Epub 2011 May 29.
4
Uptake of Gd-EOB-DTPA by hepatocellular carcinoma: radiologic-pathologic correlation with special reference to bile production.肝细胞癌对 Gd-EOB-DTPA 的摄取:与胆汁生成相关的放射-病理相关性研究。
Eur J Radiol. 2011 Dec;80(3):e243-8. doi: 10.1016/j.ejrad.2010.10.032. Epub 2010 Nov 24.
5
Hepatic hemangioma and metastasis: differentiation with gadoxetate disodium-enhanced 3-T MRI.肝血管瘤与转移瘤的鉴别:钆塞酸二钠增强 3.0T MRI 表现
AJR Am J Roentgenol. 2010 Oct;195(4):941-6. doi: 10.2214/AJR.09.3730.
6
Diagnostic performance of apparent diffusion coefficient for predicting histological grade of hepatocellular carcinoma.表观扩散系数预测肝细胞癌组织学分级的诊断性能。
Eur J Radiol. 2011 Nov;80(2):e29-33. doi: 10.1016/j.ejrad.2010.06.019. Epub 2010 Jul 8.
7
Gadoxetate disodium-enhanced MRI of the liver: part 1, protocol optimization and lesion appearance in the noncirrhotic liver.钆塞酸二钠增强肝脏 MRI:第 1 部分,方案优化和非肝硬化肝脏病变表现。
AJR Am J Roentgenol. 2010 Jul;195(1):13-28. doi: 10.2214/AJR.10.4392.
8
"Pseudo washout" sign in high-flow hepatic hemangioma on gadoxetic acid contrast-enhanced MRI mimicking hypervascular tumor.钆塞酸二钠增强 MRI 上高流量肝血管瘤的“假性洗脱”征象,类似于富血管性肿瘤。
AJR Am J Roentgenol. 2009 Dec;193(6):W490-6. doi: 10.2214/AJR.08.1732.
9
Consensus report of the 2nd International Forum for Liver MRI.第二届国际肝脏磁共振成像论坛共识报告
Eur Radiol. 2009 Oct;19 Suppl 5:S975-89. doi: 10.1007/s00330-009-1624-y.
10
Hepatocellular carcinoma with a pseudocapsule on gadolinium-enhanced MR images: correlation with histopathologic findings.钆增强磁共振成像上有假包膜的肝细胞癌:与组织病理学结果的相关性
Radiology. 2009 Feb;250(2):435-43. doi: 10.1148/radiol.2501071702. Epub 2008 Dec 18.